Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress
about
Small molecule inhibitors of zinc-dependent histone deacetylasesHistone deacetylase inhibitors for treating a spectrum of diseases not related to cancerEffects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA)Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau.Natural products as a source of Alzheimer's drug leads.Anti-inflammatory Agents: Present and FutureMercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's diseaseMulti-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.Targeting epigenetic networks with polypharmacology: a new avenue to tackle cancer.Epigenetic treatment of neurological disease.Multitarget Drugs: an Epigenetic Epiphany.Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins?A hybrid of thiazolidinone with the hydroxamate scaffold for developing novel histone deacetylase inhibitors with antitumor activities.A selective phenelzine analogue inhibitor of histone demethylase LSD1.Inhibition of Histone Deacetylase 3 Restores Amyloid-β Oligomer-Induced Plasticity Deficit in Hippocampal CA1 Pyramidal Neurons.Collagen hydrolysates increased osteogenic gene expressions via a MAPK signaling pathway in MG-63 human osteoblasts.
P2860
Q26824515-A0B39564-D432-407C-A517-8C3182BD11DCQ35016934-6573E442-3353-4905-A069-93021037A107Q35082336-0A7FC21B-C32B-417F-82F2-7BC2D90B3B9CQ36444574-C73DA30B-694D-4609-A0D2-7F3AAD4C418BQ37029561-A06AE474-DC00-4B2F-A37D-EF651B6BCFDCQ37118156-654C4740-A48D-45DD-8F01-2E4B30FFC1DFQ37190538-9B85433B-B4BC-4C1A-A441-FE027E4C30A8Q37559812-79A49201-F233-495A-BA0D-4C5B61C897A8Q37961798-97677442-B2AD-41BB-AFA2-7B9624F29E38Q37962584-A3ADE6F9-3402-464B-9B21-35BF48A1D5C4Q38739347-5E46E38E-CEA7-4D2A-B9B5-30174B47FB0AQ38784086-146709FE-87A0-4C5B-9B60-3C4A7EEABA2AQ38806404-3AE56585-3558-4BDF-838A-D511DCF8DA12Q41514691-A7ED0B61-60A8-4D32-AF24-56A378443802Q48895841-44866EF1-8297-4FFE-B9E7-DBC1DE12A869Q54379703-3E894E19-DE38-4FA6-A27A-253F62F69A0A
P2860
Searching for disease modifiers-PKC activation and HDAC inhibition - a dual drug approach to Alzheimer's disease that decreases Abeta production while blocking oxidative stress
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Searching for disease modifier ...... hile blocking oxidative stress
@ast
Searching for disease modifier ...... hile blocking oxidative stress
@en
Searching for disease modifier ...... hile blocking oxidative stress
@nl
type
label
Searching for disease modifier ...... hile blocking oxidative stress
@ast
Searching for disease modifier ...... hile blocking oxidative stress
@en
Searching for disease modifier ...... hile blocking oxidative stress
@nl
prefLabel
Searching for disease modifier ...... hile blocking oxidative stress
@ast
Searching for disease modifier ...... hile blocking oxidative stress
@en
Searching for disease modifier ...... hile blocking oxidative stress
@nl
P2093
P2860
P356
P1433
P1476
Searching for disease modifier ...... hile blocking oxidative stress
@en
P2093
Alan P Kozikowski
Brett Langley
Melissa A D'Annibale
Nancy E Lewin
Peter M Blumberg
Tapadar Subhasish
Weng-Long Wang
Yihua Chen
Zhenyu Zhong
P2860
P304
P356
10.1002/CMDC.200900045
P577
2009-07-01T00:00:00Z